Mechanisms behind tumor suppressor BAP1 highlight new treatment strategies for aggressive cancers

Scientists at the National Cancer Center Singapore and Duke-NUS Medical School discovered a novel therapeutic strategy targeting BAP1 mutations that drive aggressive cancers including mesothelioma, uveal melanoma, and cholangiocarcinoma. The research